Weight-loss ‘wonder drugs’ show a darker side as some fall into illness

Incorrect use of drugs such as Ozempic or Mounjaro can carry a big risk, writes Liz Dunphy

Georgie Aldous, an activist, model, and influencer who is campaigning for tighter regulations around the prescribing of tirzepatide, sold as Mounjaro,  after he became extremely unwell on the drug. 

‘Wonder drugs’ like Ozempic, hailed by celebrities and some medics as a cure for an ever-mounting list of conditions, most notably obesity and diabetes, have started to appear in darker headlines linked to death and disease.

In January, a grandmother in Cork died after vomiting so much on the drug that her blood pH balance became “profoundly” disarrayed and triggered organ failure less than three months after starting it.